Cite
HARVARD Citation
Smith, S. et al. (n.d.). O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies. Alzheimer's & dementia. p. P261. [Online].